Linezolid for Treatment of Nontuberculous Mycobacterial Diseases
Status:
Recruiting
Trial end date:
2021-06-15
Target enrollment:
Participant gender:
Summary
A prospective open study to determine the efficacy and tolerability of oral linezolid
600mg./day for the treatment of 40 patients with nontuberculous mycobacterial diseases will
be conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.